Global Bioenergies Sa · SWB:1DK
Global Bioenergies Sa — Investor Presentation (March 2023)
28 slides from Global Bioenergies Sa's investor presentation, March 2023
Slide 1: A growing player of the environmental transition
A growing player of the environmental transition March 2023 1
Slide 2: Disclaimer
Disclaimer This presentation contains certain forward-looking statements that have been based on current expectations about future acts, events and circumstances. These forward-looking statements are, however, subject to risks, uncertainties and assumptions that could cause those acts, events and ci
Slide 3: GBE at a glance
GBE at a glance Our Company Our Technology ✓ A unique & disruptive gaseous fermentation process ✓ Founded in 2008 ✓ synthetic biology x green chemistry = deeptech ✓ ~50 employees in the Paris area ✓ Aim to significantly contribute to cutting CO2 emissions ✓ IPO in 2011 - listed on Euronext Growth ✓
Slide 4: Why Isobutene?
Why Isobutene? • The smallest branched carbon structure (4 carbons, gaseous) • A double bond allowing the conversion of isobutene into numerous high-performance compounds: octane rating for gasoline; air tightness for elastomers; volatility for cosmetic oils… • These performances directly rely on is
Slide 5: Isobutene product tree (simplified)
Isobutene product tree (simplified) Road fuels Cosmetics Isooctane* ETBE* IDD +IHD* Other derivatives IBN Rubbers and plastics Aviation fuels Whole market: 15 million tons per year Fine chemistry isobutene produced from oil * IDD, or isododecane, is obtained by combining isobutene molecules 3 by 3 I
Slide 6: Industrial biology is a way to decarbonisation
Industrial biology is a way to decarbonisation 6
Slide 7: Our commitment: contributing to keeping the world livable
Our commitment: contributing to keeping the world livable • We aim at becoming an example for a sustainable industry • Started the Gaïa notation: – in 2021: score of 40/100, average within the companies in the same sector – in 2022: score of 56/100, above the average of 43/100 for companies with rev
Slide 8: A disruptive technology to impact the planet
A disruptive technology to impact the planet
Slide 9: A disruptive way to avoid petrochemistry
A disruptive way to avoid petrochemistry GBE’s bio-sourced process Current widespread process Residual sugars Oil VS. Petro- Biology chemistry Bacterial Steam cracking fermentation Isobutene (IBN) Green chemistry GBE’s unique technology protected by 45 patent families Isododecane (IDD) and other der
Slide 10: Unique Science
Unique Science • Engineering bacteria by implementing a metabolic pathway to IBN Genetically engineered bacteria Agricultural and IBN forestry residues • No biological starting point because IBN is not produced by Nature → We created a unique artificial metabolic pathway - huge technology barrier ov
Slide 11: Conventional resources
Conventional resources 1st generation: beet sugar residues ✓ Residue: natural and inevitable coproducts in the production process ✓ No food (nor feed) application ✓ No need for additional land ✓ Potential for high GHG emission savings French beet production: • Well established industry 40 mt • Avail
Slide 12: Emerging resources
Emerging resources 2nd generation feedstocks: wood residues and straw • Wood chips from sawmills, wheat straw… • Proven compatibility with GBE technology • New, emerging industries: first plants just starting their operations • Accessible volumes in future: several thousands of million tons, enough
Slide 13: Step by step roadmap
Step by step roadmap
Slide 14: Roadmap: 4 horizons
Roadmap: 4 horizons ¢ Global Bioenergies Horizon 4 30,000 tons/yr IBN-One 2028, France CO, savings Horizon 3 Full size plant France, mid-2026 Up to 2,000 tons/yr Market: * Million tons/year for Horizon 2 Sustainable Aviation Fuels Manufacturing chain and Low carbon Road Fuels including proprietary u
Slide 15: H1: First tons - proprietary make-up brand
H1: First tons - proprietary make-up brand ® → From Biotech to Beauty • IDD is the key, indispensable molecule in longwear make- up: being the first ingredient in proportion (25-50%), it is the universal formulation basis for eyes and lips make-up • It is also massively used in face make-up products
Slide 16: H2: A complete manufacturing chain
H2: A complete manufacturing chain Pomacle’s unit • Set-up of a complete commercial manufacturing chain in 2022 • 5 tollers + a proprietary unit built and commissionned at Toller 2 facilities in Pomacle, close to Reims 16
Slide 17: H2: First niche market - Isonaturane 12 for make-up
H2: First niche market - Isonaturane® 12 for make-up • First aim: producing IBN and converting it into cosmetic-grade IDD • IDD to be sold under brand name Isonaturane® 12: – Regulatory work completed – First large order signed by – Several smaller orders signed with brand owners and CDMOs, getting
Slide 18: H2: Second niche market - Formula 1
H2: Second niche market - Formula 1 • The FIA committed to ban fossil fuels in Formula 1 from the 2026 season on, and to run by then using 100% drop-in biofuels* • Two bio-based IBN derivatives (isooctane and ETBE) are perfectly suited for such application • The Horizon 2 manufacturing chain is at t
Slide 19: H3: Plant preliminary design
H3: Plant preliminary design Up to 2,000t/yr IBN and derivatives 19
Slide 20: H3: Scale the volumes up in cosmetics
H3: Scale the volumes up in cosmetics • Frost & Sullivan paid-for study: → IDD and sister molecule IHD widely used in four of the five cosmetics segments: make-up, skincare, haircare, toiletries → Market in tens of thousand tons per year • Isonaturane® 12 launched during largest cosmetics fairs in P
Slide 21: H3: Targeting larger niche markets
H3: Targeting larger niche markets • Manufacturing cost to go down massively from H2, based on scale economies and increased integration • Accessible volumes to increase accordingly • Products to be manufactured and sold: – Isododecane sold under brand name Isonaturane® 12 – Isohexadecane sold under
Slide 22: H3: project update
H3: project update • Up to 2,000 tons/yr IBN and derivatives • Site pre-selected in France on existing industrial park • Basic engineering completed • Special Purpose Vehicle « ViaViridia » created • Investment bank at work: Fundraising on ViaViridia targeted in Q2 2023 (equity + debt) • Latest sche
Slide 23: H4: Decarbonizing air transportation
H4: Decarbonizing air transportation • First flight performed in June 2021 with a small airplane using 97% GBE’s aviation gasoline → sends the message of our commitment to improving the sustainability of air transportation + performances of our molecules • IDD is already approved for a 50% blend in
Slide 24: H4: IATA's view
H4: IATA’s view International Air Transport Association’s view: (IATA is the trade association for the world’s airlines, representing 290 airlines or 83% of total air traffic) « » Source: www.iata.org/contentassets/b3783d24c5834634af59148c718472bb/factsheet_saf-.pdf 24
Slide 25: Road biofuels
Road biofuels • Road biofuels were considered until recently as a dead case: the electric car would become core for road transportation, and thermal engines would be banned. • Several arguments recently damaged this vision: dependency on China; effective CO2 emissions of cars, batteries, and electri
Slide 26: Conclusions
Conclusions
Slide 27: Perspectives
Perspectives • Process now mature for applications in high value niche markets: make- up and Formula 1 • Horizon 2 plant in operations / Horizon 3 plant projected for mid-2026 • Clear and stepwise roadmap to ramp the production up to Sustainable Aviation Fuels and Low Carbon Road Fuels • Potential t
Slide 28: Contact Global Bioenergies
Contact Global Bioenergies 5 rue Henri Desbruères 91000 Evry Tél. : +33 (0) 1 64 98 20 50 E-mail : invest@global-bioenergies.com
Global Bioenergies — Investor Presentation (March 2023) on 6ix